Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-21-000089

President and CEO sold 18,333 shares at an average $54.66 ($1,002,012)

From the SEC's structured data for this filing

Trades in this filing

Watts Ryan J. · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-09-01 Sale : show line 1 in the form −7,441 $54.27 $403,823 2,169,259 I
2021-09-01 Sale : show line 2 in the form −10,892 $54.92 $598,189 2,158,367 I
Open-market sales · 18,333 sh · avg $54.66 · $1,002,012
Loading xslF345X03/wf-form4_163066639800542.xml…